ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 188 filers reported holding ARCUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $270,542 | -11.0% | 15,072 | +0.7% | 0.00% | 0.0% |
| Q2 2023 | $304,081 | -4.7% | 14,972 | -14.4% | 0.00% | 0.0% |
| Q1 2023 | $319,054 | -11.8% | 17,492 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $361,735 | -27.7% | 17,492 | -8.5% | 0.00% | 0.0% |
| Q3 2022 | $500,000 | +3.1% | 19,122 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $485,000 | -9.5% | 19,122 | +12.7% | 0.00% | 0.0% |
| Q1 2022 | $536,000 | -32.7% | 16,972 | -13.9% | 0.00% | 0.0% |
| Q4 2021 | $797,000 | +6.0% | 19,702 | -8.7% | 0.00% | 0.0% |
| Q3 2021 | $752,000 | +27.0% | 21,576 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $592,000 | +54.6% | 21,576 | +58.1% | 0.00% | 0.0% |
| Q1 2021 | $383,000 | +9.4% | 13,650 | +1.1% | 0.00% | 0.0% |
| Q4 2020 | $350,000 | +60.6% | 13,500 | +6.2% | 0.00% | – |
| Q3 2020 | $218,000 | -26.8% | 12,710 | +5.6% | 0.00% | -100.0% |
| Q2 2020 | $298,000 | +88.6% | 12,040 | +5.5% | 0.00% | – |
| Q1 2020 | $158,000 | – | 11,414 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |